Quinapril HCL and Hydrochlorothiazide (Lupin Pharmaceuticals,Inc.)
Welcome to the PulseAid listing for the Quinapril HCL and Hydrochlorothiazide drug offered from Lupin Pharmaceuticals,Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals,Inc. |
| NON-PROPRIETARY NAME: | Quinapril HCl and Hydrochlorothiazide |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-07-15 |
| END MARKETING DATE: | 0000-00-00 |
Quinapril HCL and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Quinapril HCL and Hydrochlorothiazide from Lupin Pharmaceuticals,Inc. |
| LABELER NAME: | Lupin Pharmaceuticals,Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2011-07-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43386-710_7a142355-ef5d-463b-9890-601c59175418 |
| PRODUCT NDC: | 43386-710 |
| APPLICATION NUMBER: | ANDA076374 |
Other QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
